Terms: = Leukemia AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1 AND Clinical Outcome
2 results:
1. PAK5 is a potential target in myelodysplastic syndrome through interacting with LMO2 and gata1.
Pan X; Liu D; Ying M; Zheng G; Fan C; Pan F; Ke Q
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(9):77-85. PubMed ID: 36905268
[TBL] [Abstract] [Full Text] [Related]
2. clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome.
Dixon N; Kishnani PS; Zimmerman S
Am J Med Genet C Semin Med Genet; 2006 Aug; 142C(3):149-57. PubMed ID: 17048354
[TBL] [Abstract] [Full Text] [Related]
